SB-269970

DB13988ExperimentalSmall molecule

SB-269970 is an experimental drug developed by GlaxoSmithKline. In the studies performed with this agent, it has been suggested that SB-269970 acts either as a selective antagonist or inverse agonist...

Formula / weight: C₁₈H₂₈N₂O₃S · 352.49 g/mol (avg)
Code names: SB-269970

Resolves to

Compound

UNIIKC8KP5XU6FCAS201038-74-6ChEMBLCHEMBL282199ChEBI92426

Structure

InChIKeyHWKROQUZSKPIKQ-MRXNPFEDSA-NSMILESCC1CCN(CC[C@H]2CCCN2S(=O)(=O)C2=CC=CC(O)=C2)CC1

Targets

P34969HTR7

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with SB-269970, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account